On May 14, 2025, NKGen Biotech, Inc. signed a Stock Purchase Agreement to sell 19,669,552 shares of common stock at $0.1271 per share for $2.5 million. This agreement also includes a warrant for purchasing an additional 39,339,103 shares at the same price.